Nucleoside analogue

Guanosine_aciclovir_comparison.svg

Nucleoside analogue

A nucleoside analogue is a type of antiviral drug that resembles the building blocks of nucleic acids. These analogues are structurally similar to naturally occurring nucleosides, which are the components of nucleotides, the building blocks of DNA and RNA. Nucleoside analogues are used primarily in the treatment of viral infections and certain types of cancer.

Mechanism of Action

Nucleoside analogues work by interfering with the synthesis of nucleic acids. When these analogues are incorporated into a growing DNA or RNA strand during replication, they can cause premature chain termination or introduce mutations. This disrupts the replication process of the virus or cancer cell, ultimately inhibiting its ability to proliferate.

Types of Nucleoside Analogues

There are several types of nucleoside analogues, each designed to target specific viruses or cancer cells. Some of the most commonly used nucleoside analogues include:

• Acyclovir - used to treat herpes simplex virus infections.
• Zidovudine (AZT) - used in the treatment of HIV/AIDS.
• Gemcitabine - used in the treatment of various cancers, including pancreatic cancer and non-small cell lung cancer.

Clinical Applications

Nucleoside analogues are used in the treatment of a variety of diseases, including:

• HIV/AIDS: Nucleoside reverse transcriptase inhibitors (NRTIs) like zidovudine and lamivudine are essential components of antiretroviral therapy.
• Herpesvirus Infections: Drugs like acyclovir and valacyclovir are used to manage infections caused by herpes simplex virus and varicella-zoster virus.
• Cancer: Nucleoside analogues such as gemcitabine and cytarabine are used in chemotherapy regimens for various types of cancer.

Side Effects

The use of nucleoside analogues can be associated with several side effects, which may vary depending on the specific drug and the condition being treated. Common side effects include:

• Nausea
• Vomiting
• Bone marrow suppression
• Liver toxicity

Research and Development

Ongoing research aims to develop new nucleoside analogues with improved efficacy and reduced toxicity. Advances in molecular biology and pharmacology continue to drive the discovery of novel compounds that can target a broader range of viruses and cancer cells.

See Also

• Antiviral drug
• Chemotherapy
• Nucleic acid
• Nucleotide
• Reverse transcriptase inhibitor